HomeCompareSDMHF vs PLD

SDMHF vs PLD: Dividend Comparison 2026

SDMHF yields 0.39% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $5.56M in total portfolio value
10 years
SDMHF
SDMHF
● Live price
0.39%
Share price
$193.00
Annual div
$0.75
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$351.4K
Annual income
$234,602.49
Full SDMHF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — SDMHF vs PLD

📍 PLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSDMHFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SDMHF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SDMHF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SDMHF
Annual income on $10K today (after 15% tax)
$32.81/yr
After 10yr DRIP, annual income (after tax)
$199,412.12/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $3,838,704.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SDMHF + PLD for your $10,000?

SDMHF: 50%PLD: 50%
100% PLD50/50100% SDMHF
Portfolio after 10yr
$3.13M
Annual income
$2,492,663.84/yr
Blended yield
79.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

SDMHF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
3.9
Piotroski
7/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SDMHF buys
0
PLD buys
0
No recent congressional trades found for SDMHF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSDMHFPLD
Forward yield0.39%3.10%
Annual dividend / share$0.75$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%74.4%
Portfolio after 10y$351.4K$5.91M
Annual income after 10y$234,602.49$4,750,725.19
Total dividends collected$321.4K$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy

Year-by-year: SDMHF vs PLD ($10,000, DRIP)

YearSDMHF PortfolioSDMHF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$10,777$77.20$11,241$540.96$464.00PLD
2$11,687$155.52$13,019$991.13$1.3KPLD
3$12,820$315.23$15,801$1,870.97$3.0KPLD
4$14,364$646.35$20,609$3,701.21$6.2KPLD
5$16,723$1,353.62$29,919$7,867.97$13.2KPLD
6$20,840$2,945.67$50,631$18,617.74$29.8KPLD
7$29,160$6,861.15$105,528$51,352.20$76.4KPLD
8$49,145$17,944.60$287,364$174,449.42$238.2KPLD
9$109,116$56,530.29$1,081,760$774,280.77$972.6KPLD
10$351,356$234,602.49$5,908,209$4,750,725.19$5.56MPLD

SDMHF vs PLD: Complete Analysis 2026

SDMHFStock

Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.

Full SDMHF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this SDMHF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SDMHF vs SCHDSDMHF vs JEPISDMHF vs OSDMHF vs KOSDMHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.